Introduction
Male infertility in subjects with azoospermia or severe oligozoospermia with unknown aetiology was first associated with a possible genetic cause by Tiepolo and Zuffardi (1976) , in a report of six azoospermic patients carrying a deletion of the distal portion of Y chromosome long arm. On the basis of this finding they proposed the existence of a spermatogenesis gene, the 'azoospermia factor' (AZF) on Yq.
Confirmatory data for the actual presence of genes of spermatogenesis in Yq had to wait until molecular maps of Y chromosome and molecular tools for mapping microdeletions were made available. DNA probes specific for Y chromosome loci (Vergnaud et al., 1986) or polymerase chain reaction (PCR) amplification of sequence-tagged sites (STS) (Vollrath et al., 1992) have allowed the identification of microdeletions in Yq regions known not to pair or recombine with the X chromosome.
Up to now, three non-overlapping loci have been identified on Yq11; and their deletion is associated with sterility (azoospermia or severe oligospermia) (Vogt et al., 1996) . Two have been localized to interval 6 of Yq11 and are called AZFb and AZFc, and one is more proximal to the centromere in Yq11 and is called AZFa. In interval 6 of Yq11, two genes have been identified that are deleted in a number of infertile men; one is the Y chromosome RNArecognition motif (YRRM/RBM) identified by Ma et al. (1993) , the other is the Deleted in AZoospermia gene (DAZ) identified by Reijo et al. (1995) . The first gene RBM, has
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© European Society of Human Reproduction and Embryology been tentatively linked with AZF (Ma et al., 1993) and is a member of an RNA-binding protein gene family, which is represented in multiple copies in different regions of the Y chromosome, and at least one copy is localized to the AZFb region (Elliott et al., 1997) . The second gene, DAZ, is at present the strongest candidate for AZF, and its deletion has been found to be associated with a wide range of spermatogenic defects from bona fide Sertoli cell-only (SCO) syndrome to reduced spermatogenesis resulting in severe oligozoospermia (Reijo et al., 1995 (Reijo et al., , 1996 . In the proximal region of Yq11 the gene DFFRY has been recently linked to AZFa. This gene is the Y-linked homologue of the DFFRX (Drosophila fat-facets related X gene), and it has been shown to be deleted in three azoospermic males (Brown et al., 1998) . However it must be stressed that the rare deletions in this locus (from 1-5% in different surveys) generally associate with a SCO phenotype (Ma et al., 1992; Vogt et al., 1996) , with the exception of one published case showing reduced spermatogenesis (Qureshi et al., 1996) , thus suggesting that this locus is important for early steps of spermatogenesis, possibly in prenatal development. As a whole the data available would indicate that AZF is a multigene complex preferentially located in Yq11, whose members might act at specific differentiative steps of spermatogenesis.
In the present report we analysed 67 azoospermic and severe oligozoospermic patients for the presence of microdeletions in Yq11 using 18 STS and two DNA probes. We found four subjects with deletions in AZFc, including the DAZ gene, and one patient with deletions in AZFa.
Materials and methods

Clinical subjects
Patients affected by azoospermia (n ϭ 60) and oligozoospermia (n ϭ 7) (sperm concentration Ͻ1ϫ10 6 /ml) were analysed in this study. A total of 40 patients were recruited for a prospective study from the andrology clinic clientele of the University of Roma 'La Sapienza' and Florence, while 27 were analysed retrospectively. Patients with varicocele and with a history of cryptorchidism were not excluded from our screening, while patients with obstruction of the seminal ducts, as evaluated with the analysis of the seminal markers of duct patency such as fructose, carnitine and citric acid, were excluded.
Semen analysis was performed according to the World Health Organization parameters. Serum follicle stimulating hormone (FSH), luteinizing hormone (LH) and testosterone were measured by radioimmunoassay, according to methods of Fabbri et al. (1988) .
All patients had a normal 46,XY karyotype, thus excluding chromosomal aberrations associated with male sterility.
PCR amplification of STS
Genomic DNA of each patient was obtained from peripheral blood leukocytes using the Nucleon Kit II (Scotlab, Wiesloch, Germany). PCR amplification was performed with a set of 18 pairs of oligonucleotide primers for Y-specific STS (Vollrath et al., 1992; Reijo et al., 1995) . The STS analysed were: sY83, sY84, sY86, sY87 (located in AZFa), sY117 (located in AZFb), and sY164, sY55, sY132, sY112, sY152, sY155, sY242, sY254, sY283, sY277, sY236, sY202, sY157 (located in AZFc). The STS selected in this study were normally amplified in control males and were absent in control females, thus suggesting Y chromosome specificity. One STS specific for the gene SRY, located in Yp, was also analysed. PCR reactions were carried out by 35 cycles with 94°C for 1 min, 60°C for 1 min and 72°C for 1.2 min. Each PCR reaction was generally performed using two pairs of primers. The PCR products were separated on 1.5% agarose gel.
Southern blot analysis
Samples (10 µg) of each genomic DNA were digested with EcoRI for probe p50f2 and with TaqI for probe p49f and separated by electrophoresis on 1% agarose gel in tris-borate-EDTA (TBE) buffer. The DNA samples in the gel were first denatured by treatment with 1.5 M NaCl, 0.5 M NaOH, and then neutralized with 1.5 M NaCl, 0.5 M Tris-HCl (pH 8). The DNA samples were transferred to Hybond-N nylon membrane (Amersham, UK) in 10ϫ sodium chloride/sodium citrate (SSC) and then fixed by 1200 J UV irradiation.
The probes used in our analysis were either purified PCR-amplified STS or Y-chromosome DNA fragments (p50f2 and p49f), generously provided by J.Weissembach. The probes were labelled with α-[ 32 P]-dATP, by using the random-primed DNA labelling kit (Boehringer Mannheim, Mannheim, Germany). Prehybridization was performed at 68°C for 1 h in QuikHyb hybridization solution (Stratagene, La Jolla, CA) and was followed by hybridization in the same solution for 1 h at 68°C in the presence of 100 µg/ml of salmon sperm DNA and radiolabelled probe at 1ϫ10 6 c.p.m./ml. The membrane was washed first twice with 2ϫ SSC, 0.1% sodium dodecyl sulphate (SDS) for 15 min at room temperature and then with 0.2ϫ SSC, 0.2% SDS for 30 min at 60°C and then exposed for autoradiography.
Results
The 67 patients with azoospermia or severe oligozoospermia, selected as described in Methods, were screened by PCR amplification and Southern blot analysis for potential deletions of 20 loci on Yq11. STSs and Y chromosome DNA probes used in this study, and their localization on Yq11 are shown in Figure 1 . Most of the STS map to interval 6 of Yq11, which includes the DAZ gene in AZFc locus (sY254, sY277, sY283). Four STS (sY83, sY84, sY86, sY87) map to AZFa, and another STS (sY117) maps to AZFb.
We detected deletions on Yq11 in five patients by PCR amplification. Figure 2 shows the Y-specific STS found deleted: patients SP8, FO3, FA16, and FA45 showed deletions in Figure 3 . Representative Southern blots using as probe: (A) the purified polymerase chain reaction (PCR) products sY254, sY277, sY283, as indicated in figure; (B) the DNA fragment p49f; (C) the DNA fragment p50f2. Genomic DNA was digested with EcoRI in (A) and (C) and with TaqI in (B). The size of the Y-specific fragments in (A) is~1.7 kbp for sY254, 3.0 kbp for sY283 and 1.7-1.8 kbp for sY277. The sizes of the visible bands in panels B and C corresponded to those previously described for (B) (Saxena et al., 1996) and (C) (Ma et al., 1992) . The control fertile male and female allow discrimination between Y-specific and X autosomal bands. In (B) and (C) the azoospermic patient SP1 with no Yq microdeletions is also included. The arrow in (C) indicates the band corresponding to locus DYS7-C in the AZFc region of Yq (see Figure 1) found deleted in patient SP8. Probe p50f2 recognizes additional bands (A, B, D and E) corresponding to locus DYS7-A and -B in Yp, DYS7-D in the centromere, and DYS7-E in the AZFb region of Yq.
AZFc involving the DAZ locus and patient FA14 showed microdeletions in AZFa. Patients SP8 and FO3 showed deletions with the same extension including STS sY152, sY242, sY254, sY277 and sY283 but differed for STS sY155, which was deleted in FO3 and present in SP8. Patient FA16 showed a slightly shorter deleted region including STS from sY155 to sY277. Patient FA45 has a unique pattern of deletion in our screening, limited to the DAZ locus (sY277, sY254, sY283). The absence of the DAZ locus was confirmed in patients SP8, FO3 and FA16 by Southern blot analysis, using as a probe the same PCR product found deleted. Figure 3A shows a representative Southern blot experiment using STS sY254, sY277, sY283 as probes. DNA from the same patients was also analysed by a hybridization technique using the Y chromosome DNA probes p49f and p50f2 (see map in Figure 1) , showing deletions of both loci DYS1 (detected by p49f) and DYS7C (detected by p50f2) (Figure 3B,C) . The absence, in these patients, of DYS1 sequences, previously demonstrated to be 1118 the DAZ gene cluster (Saxena et al., 1996) , agrees with PCR data. The available DNA from the other DAZ-deleted patient FA45 was not sufficient for Southern analysis.
Three more patients showed microdeletions of a single STS in AZFc by PCR amplification, being sY283 negative in two cases and sY157 in the third one. Although the PCR amplification was repeatedly negative in separate reactions, we demonstrated that they were false negatives, by a Southern blot study using as probe the same PCR product found deleted.
The FA14 patient showed microdeletions only in AZFa, including the STS sY84, sY86, sY87, and sY83 (Figure 2) . All other STS analysed in patient FA14 were normally amplified. Southern blot analysis using these STS as probes did not give conclusive results due to cross-reactivity with autosomal DNA.
The clinical parameters of the five patients with microdeletions are summarized in Table I . Four patients were azoospermic and only the DAZ-deleted FO3 patient showed very rare and aberrant spermatozoa.
Testicular histology was available in three deleted patients. FA14, carrying microdeletions in AZFa, had Sertoli cell-only syndrome with complete lack of germ cells. Patients carrying deletion of the DAZ gene (SP8 and FA45) showed different spermatogenic defects including Sertoli cell-only syndrome and maturation arrest. Testicular histology of patient FA45 carrying a DAZ deletion was associated with a SCO phenotype and is shown in Figure 4 .
Discussion
Spermatogenesis is a complex event leading to the formation of mature spermatozoa, occurring under the control of a wide variety of factors acting from prenatal to adult life (Vogt, 1997 ). An important role in the regulation of spermatogenesis is certainly played by the genetic programming of germ cell itself based both on autosomal and sex chromosomal genes. A group of idiopathic infertility has been, in fact, associated with genetic causes linked to the Y chromosome and many studies have recently shown deletions on Y chromosome long arm in idiopathic azoospermic males. The frequencies of deletions of Yq, reported in different studies, range between 3 and 18% of males with non-obstructive azoospermia or severe oligozoospermia (Reijo et al., 1995; Stuppia et al., 1996; Vogt et al., 1996; Girardi et al., 1997; Pryor et al., 1997; Qureshi et al., 1997; Simoni et al., 1997; Van der Ven et al., 1997) . In our screening of 67 infertile males we have found five patients carrying microdeletions, corresponding to a frequency of 7.5%, that perfectly agrees with the statistical value obtained averaging all the surveys reported to date (Simoni et al., 1998) . The frequency of microdeletions reported here is the result of a correction of the PCR data, made on the basis of Southern blot analyses. In fact, we could exclude three more patients showing a single STS deletion by PCR amplification, not confirmed by Southern blotting, thus lowering the microdeletion rate from~12% to 7.5%. Even though it is not possible from our result to evaluate statistically whether some STS are more prone to give false negatives, or whether this technical problem might be relevant in explaining the higher frequency of microdeletions found by others, in our opinion Southern blot analysis has to be performed at least in those cases where PCR reaction fails to amplify a single STS. However, we cannot exclude the possibility that the failure of PCR amplification in Southern blot positive cases is due to mutations or small deletions occurring in the genomic sequence matching the STS primers that we used. This should be investigated by sequence analysis of wider genomic regions spanning the involved STS. We could not obtain control DNA of fathers or brothers of the patients carrying Yq microdeletions, thus the possibility that some of the deletions that we have identified simply reflect polymorphisms cannot be excluded. However, larger studies have shown that most of Yq microdeletions are not paternally inherited (Reijo et al., 1995) , therefore they must occur de novo at some stage of paternal germ cell differentiation (at stages compatible with completion of sperm cell differentiation and fertilization even in the lack of the affected gene) or possibly in fertilized eggs (Edwards and Bishop, 1997) .
As for the mechanism of the appearance of microdeletions, it has been suggested the occurrence of an intrachromosomal recombination event between repeated sequences flanking the affected gene, causing a loop that is deleted (Edwards and Bishop, 1997) . If this is the case, the possibility exists of more such events in the same chromosome causing discontinuous deletions, e.g. the one observed in patient SP8.
Many efforts have been made to identify the genes on Yq that are important for a normal spermatogenesis (Lahn and Page, 1997) , but up to now the gene/s that are absolutely required for germ cell development have not been characterized. The first genes identified on Yq that could be involved in the control of spermatogenesis belong to the RBM gene family, and include up to 30 copies of genes and pseudogenes, spread over both arms of the Y chromosome (Ma et al., 1993) . RBM genes encode RNA-binding proteins and are specifically expressed in spermatogonia and early spermatocytes (Chandley and Cooke, 1994) . The RBM1 gene has been mapped to the AZFb region of the Yq (Vogt. et al., 1996; Elliott et al., 1997) , but the precise role of this gene in spermatogenesis is not clear, since it is present in many azoospermic males.
The other candidate gene for AZF is DAZ which, similar to the RBM1 gene, encodes a protein with an RNA-binding motif and is present in multiple copies (at least two or three copies) on Yq. The DAZ gene has been mapped to the AZFc region of the Yq (Vogt et al., 1996) and is specifically expressed in spermatogonia in the testis (Menke et al., 1997) . Deletions of DAZ gene are found frequently in azoospermic or in severe oligozoospermic males and no point mutations have been identified up to now (Vereb et al., 1997) . However, the observation that loss-of-function mutations of Boule, the DAZ homologue in Drosophila, results in azoospermia (Eberhart et al., 1996) , strongly supports a critical role for the DAZ gene in spermatogenesis. The functional role of DAZ has not been characterized, and the range of testicular histology observed in DAZ-deleted patients varies from very severe defects in spermatogenesis, e.g. SCO, to severe reduction in sperm production with oligozoospermia (Ͻ1ϫ10 6 /ml) (Reijo et al., 1996) . In our study, testicular histology of the patients carrying deletion of DAZ showed in patient FA45 a Sertoli cell-only syndrome and in patient SP8 a maturative arrest. Moreover, patient FO3, also carrying the DAZ deletion but whose biopsy was not available, showed cryptoazoospermia in the ejaculate. These observations suggest that different co-factors could modulate the strength of the mutation and that deletion of DAZ is compatible with completion of spermatogenesis at very low levels (Mulhall et al., 1997) .
The correlation between DAZ mutations and testis phenotype is further complicated by two other considerations: the first derives from the observation that the structure of the DAZ gene is characterized by 16 exons and multiple copies of a repeat in tandem array (Saxena et al., 1996) , and by the presence in the male population of a polymorphism in the number of the DAZ repeats resulting in the possible transcription of different functional DAZ genes (Yen et al., 1997) . The second consideration is based on the presence of a DAZ homologue, called DAZLA (DAZ-Like Autosomal), which has been identified on chromosome 3 (Saxena et al., 1996) . DAZLA is expressed specifically in the testis and could be involved in autosomal recessive male infertility. A possible involvement of the autosomal homologue in spermatogenesis is supported by the observation that in mouse the homologue of DAZ, dazla, is autosomal (Cooke et al., 1996) and its targeted disruption leads to a complete absence of gamete production in both testis and ovary demonstrating that dazla is essential for development and survival of germ cells (Ruggiu et al., 1997) .
In the AZFa region of the Y chromosome, the gene DFFRY, the Y-linked homologue of the Drosophila DFFRX gene, has been identified recently (Brown et al., 1998) . This gene encodes a protein related to ubiquitin action and, hence, is involved in protein turnover. We have identified one patient (FA14) with microdeletions in the AZFa region, whose testicular histology showed Sertoli-cell only syndrome in which all the tubules analysed lacked germ cells. This is in line with observations by Ma et al. (1992) and Vogt et al. (1996) , which confirm that deletions proximal to the centromere in Yq are linked to a spermatogenic defect that probably occurs during the proliferation of spermatogonia, before puberty.
A final consideration should be made on the possible occurrence of mosaicism of Yq microdeletions arising postzygotically, which might decrease the probability of detection of genetic defects by PCR or Southern techniques, using DNA from blood cells as a template. It is important to verify the frequency of this situation, in order to evaluate the necessity to extend PCR analysis of DNA from peripheral blood to sperm samples or testis biopsies, to avoid mis-detection due to mosaicism. In our opinion, however, molecular diagnosis, optimized by Southern blotting to confirm PCR results, should be recommended to those patients with azoospermia or severe oligozoospermia (Ͻ1ϫ10 6 /ml), who are seeking assisted fertilization by intracytoplasmic sperm injection for correct information on the possibility of the transmission of molecular defects to male offspring (Silber et al., 1995; Bonduelle et al., 1996) .
